HSBC Knock-Out ABBV/ DE000HS44HR9 /
2024-06-28 10:00:43 AM | Chg.0.000 | Bid10:17:32 AM | Ask10:17:32 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.370EUR | 0.00% | 0.370 Bid Size: 30,000 |
0.380 Ask Size: 30,000 |
AbbVie Inc | 208.6281 USD | 2078-12-31 | Put |
GlobeNewswire
8:00 AM
Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Re...
GlobeNewswire
1:10 AM
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
06-27
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Ach...
GlobeNewswire
06-25
CEREVEL (NASDAQ:CERE) STOCK ALERT: Cerevel’s $45 Per Share Deal is Being Investigated by BFA Law, Sh...
GlobeNewswire
06-24
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
06-22
CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law...
GlobeNewswire
06-21
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
06-20
CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law...
GlobeNewswire
06-20
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
06-19
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire
06-19
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire
06-18
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire
06-18
CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoi...
GlobeNewswire
06-17
Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, B...
GlobeNewswire
06-15
CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law abo...
GlobeNewswire
06-13
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire
06-13
CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investi...
GlobeNewswire
06-13
What Employees at the Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area Value Mo...
GlobeNewswire
06-12
US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...